Digital Biomarkers and Sex Impacts in Alzheimer's Disease Management - Potential Utility for Innovative 3P Medicine Approach

Overview

Journal EPMA J

Date 2022 Jun 20

PMID 35719134

Authors

Robbert L Harms

Alberto Ferrari

Irene B Meier

Julie Martinkova

Enrico Santus

Nicola Marino

Davide Cirillo

Simona Mellino

Silvina Catuara Solarz

Ioannis Tarnanas

Cassandra Szoeke

Jakub Hort

Alfonso Valencia

Maria Teresa Ferretti

Azizi Seixas

Antonella Santuccione Chadha

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s13167-022-00284-3.

Citing Articles

Digital biomarkers: 3PM approach revolutionizing chronic disease management - EPMA 2024 position.

Smokovski I, Steinle N, Behnke A, Bhaskar S, Grech G, Richter K EPMA J. 2024; 15(2):149-162.

PMID: 38841615 PMC: 11147994. DOI: 10.1007/s13167-024-00364-6.

Definitions of digital biomarkers: a systematic mapping of the biomedical literature.

Macias Alonso A, Hirt J, Woelfle T, Janiaud P, Hemkens L BMJ Health Care Inform. 2024; 31(1).

PMID: 38589213 PMC: 11015196. DOI: 10.1136/bmjhci-2023-100914.

Ethical issues when using digital biomarkers and artificial intelligence for the early detection of dementia.

Ford E, Milne R, Curlewis K Wiley Interdiscip Rev Data Min Knowl Discov. 2024; 13(3):e1492.

PMID: 38439952 PMC: 10909482. DOI: 10.1002/widm.1492.

Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging.

Farvadi F, Hashemi F, Amini A, Alsadat Vakilinezhad M, Javad Raee M Int J Mol Cell Med. 2024; 12(2):172-210.

PMID: 38313372 PMC: 10837916. DOI: 10.22088/IJMCM.BUMS.12.2.172.

Alzheimer's in the modern age: Ethical challenges in the use of digital monitoring to identify cognitive changes.

Erickson C, Wexler A, Largent E Inform Health Soc Care. 2023; 49(1):1-13.

PMID: 38116960 PMC: 11001527. DOI: 10.1080/17538157.2023.2294203.

References

van der Hoek M, Nieuwenhuizen A, Keijer J, Ashford J . The MemTrax Test Compared to the Montreal Cognitive Assessment Estimation of Mild Cognitive Impairment. J Alzheimers Dis. 2019; 67(3):1045-1054. PMC: 6398548. DOI: 10.3233/JAD-181003. View

Metz C . Basic principles of ROC analysis. Semin Nucl Med. 1978; 8(4):283-98. DOI: 10.1016/s0001-2998(78)80014-2. View

Jakobi J, Haynes E, Smart R . Is there sufficient evidence to explain the cause of sexually dimorphic behaviour in force steadiness?. Appl Physiol Nutr Metab. 2018; 43(11):1207-1214. DOI: 10.1139/apnm-2018-0196. View

Sundermann E, Barnes L, Bondi M, Bennett D, Salmon D, Maki P . Improving Detection of Amnestic Mild Cognitive Impairment with Sex-Specific Cognitive Norms. J Alzheimers Dis. 2021; 84(4):1763-1770. DOI: 10.3233/JAD-215260. View

Hampel H, OBryant S, Castrillo J, Ritchie C, Rojkova K, Broich K . PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease. J Prev Alzheimers Dis. 2017; 3(4):243-259. PMC: 5363725. DOI: 10.14283/jpad.2016.112. View

Lin K, Roy Choudhury K, Rathakrishnan B, Marks D, Petrella J, Doraiswamy P . Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimers Dement (N Y). 2015; 1(2):103-110. PMC: 4593067. DOI: 10.1016/j.trci.2015.07.001. View

Inan O, Tenaerts P, Prindiville S, Reynolds H, Dizon D, Cooper-Arnold K . Digitizing clinical trials. NPJ Digit Med. 2020; 3:101. PMC: 7395804. DOI: 10.1038/s41746-020-0302-y. View

Li X, Dunn J, Salins D, Zhou G, Zhou W, Schussler-Fiorenza Rose S . Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information. PLoS Biol. 2017; 15(1):e2001402. PMC: 5230763. DOI: 10.1371/journal.pbio.2001402. View

Buegler M, Harms R, Balasa M, Meier I, Exarchos T, Rai L . Digital biomarker-based individualized prognosis for people at risk of dementia. Alzheimers Dement (Amst). 2020; 12(1):e12073. PMC: 7437401. DOI: 10.1002/dad2.12073. View

10.

Ferretti M, Iulita M, Cavedo E, Chiesa P, Dimech A, Chadha A . Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018; 14(8):457-469. DOI: 10.1038/s41582-018-0032-9. View

11.

Gualtieri C, Johnson L . Neurocognitive testing supports a broader concept of mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2006; 20(6):359-66. PMC: 10833282. DOI: 10.1177/153331750502000607. View

12.

DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

13.

Junkkila J, Oja S, Laine M, Karrasch M . Applicability of the CANTAB-PAL computerized memory test in identifying amnestic mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord. 2012; 34(2):83-9. DOI: 10.1159/000342116. View

14.

Weis S, Patil K, Hoffstaedter F, Nostro A, Yeo B, Eickhoff S . Sex Classification by Resting State Brain Connectivity. Cereb Cortex. 2019; 30(2):824-835. PMC: 7444737. DOI: 10.1093/cercor/bhz129. View

15.

Lundberg S, Erion G, Chen H, DeGrave A, Prutkin J, Nair B . From Local Explanations to Global Understanding with Explainable AI for Trees. Nat Mach Intell. 2020; 2(1):56-67. PMC: 7326367. DOI: 10.1038/s42256-019-0138-9. View

16.

Coravos A, Khozin S, Mandl K . Developing and adopting safe and effective digital biomarkers to improve patient outcomes. NPJ Digit Med. 2019; 2(1). PMC: 6411051. DOI: 10.1038/s41746-019-0090-4. View

17.

Ferretti M, Martinkova J, Biskup E, Benke T, Gialdini G, Nedelska Z . Sex and gender differences in Alzheimer's disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology. Eur J Neurol. 2020; 27(6):928-943. DOI: 10.1111/ene.14174. View

18.

Sundermann E, Biegon A, Rubin L, Lipton R, Mowrey W, Landau S . Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology. 2016; 86(15):1368-1376. PMC: 4831033. DOI: 10.1212/WNL.0000000000002570. View

19.

Serrano-Pozo A, Frosch M, Masliah E, Hyman B . Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2012; 1(1):a006189. PMC: 3234452. DOI: 10.1101/cshperspect.a006189. View

20.

Harrold J, Ramanathan M, Mager D . Network-based approaches in drug discovery and early development. Clin Pharmacol Ther. 2013; 94(6):651-8. PMC: 4701200. DOI: 10.1038/clpt.2013.176. View